Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-004144-74Phase 4Terminated
Phase 4 trial of insulin detemir and insulin glargine in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: BMI standard deviation score after 1 year. Started Oct 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-004144-74.